Covid-19 Medicine: A drug approved against corona in the US, patients with mild-to-moderate symptoms will be treated

Another new drug has been approved against Corona in the US. The US Food and Drug Administration approved the emergency use of an antibody drug developed by Veer Biotechnology (VIR.O) and GlaxoSmithKline (GSK.L) for the treatment of mild to moderate COVID-19 in people 12 years and older. is. The health regulator said Wednesday that the antibody drug, Sotrovimab, is not authorized for corona patients who are hospitalized due to corona infection or require oxygen therapy.

Sotrovimab belongs to a class of drugs called monoclonal antibodies, which mimic the natural antibodies that the body produces to fight infection. Antibody treatment will be available to Korana virus patients in the coming weeks, with GSK and Vir stating that they planned to submit a marketing application to the FDA in the second half of 2021.

Similar COVID-19 drugs have previously been authorized for emergency use in the United States by Regeneron Pharmaceuticals (REGN.O) and Eli Lilly (LLY.N).

Corona drug given to Trump launched in India

The drug, given to former US President Donald Trump after being infected with Corona, was launched in India on Monday. The drug company Roche India, along with Cipla, has launched this antibody cocktail drug. Giving this medicine to mild and moderately infected patients reduces their risk of becoming severe and hospitalized. One dose of this is about 60 thousand rupees. For the treatment of corona, a dose is prepared by mixing two drugs called Casirivimav and Imdevimav, hence the drug is named Antibody Cocktail. In October last year, Trump was given this medicine when he had a corona.